Aaron Prodeus

677 total citations
21 papers, 460 citations indexed

About

Aaron Prodeus is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Aaron Prodeus has authored 21 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Immunology. Recurrent topics in Aaron Prodeus's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Aaron Prodeus is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Aaron Prodeus collaborates with scholars based in Canada, United States and Italy. Aaron Prodeus's co-authors include Jean Gariépy, Nicholas W. Fischer, Marzena Cydzik, Aws Abdul‐Wahid, Eric H.‐B. Huang, David Malkin, Kullervo Hynynen, David E. Goertz, John E. Shively and Christina R. Lee and has published in prestigious journals such as Blood, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Aaron Prodeus

21 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aaron Prodeus Canada	12	227	171	133	94	41	21	460
Jonathan Lerner United States	6	162 0.7×	110 0.6×	110 0.8×	60 0.6×	50 1.2×	7	441
James Ross United States	12	184 0.8×	140 0.8×	214 1.6×	74 0.8×	91 2.2×	24	559
Jun Deng China	13	230 1.0×	178 1.0×	122 0.9×	61 0.6×	82 2.0×	30	460
Jingfang Xiao China	9	145 0.6×	121 0.7×	144 1.1×	48 0.5×	70 1.7×	12	398
Cécile Henry France	10	205 0.9×	98 0.6×	63 0.5×	50 0.5×	76 1.9×	19	405
Yong-Kil Hong South Korea	11	149 0.7×	134 0.8×	128 1.0×	42 0.4×	56 1.4×	22	409
Chia‐Ing Jan Taiwan	14	305 1.3×	142 0.8×	116 0.9×	134 1.4×	151 3.7×	21	633
Yuncheng Bei China	9	150 0.7×	276 1.6×	253 1.9×	59 0.6×	46 1.1×	14	474
Águeda Martínez‐Barriocanal Spain	13	163 0.7×	91 0.5×	210 1.6×	31 0.3×	81 2.0×	20	437
Raziye Piranlioglu United States	9	199 0.9×	251 1.5×	276 2.1×	57 0.6×	92 2.2×	13	517

Countries citing papers authored by Aaron Prodeus

Since Specialization

Citations

This map shows the geographic impact of Aaron Prodeus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Prodeus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Prodeus more than expected).

Fields of papers citing papers by Aaron Prodeus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Prodeus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Prodeus. The network helps show where Aaron Prodeus may publish in the future.

Co-authorship network of co-authors of Aaron Prodeus

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Prodeus. A scholar is included among the top collaborators of Aaron Prodeus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Prodeus. Aaron Prodeus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prodeus, Aaron, Sayaka Nakamura, Jason S. Rockel, et al.. (2022). Can CD200R1 Agonists Slow the Progression of Osteoarthritis Secondary to Injury?. Frontiers in Immunology. 13. 836837–836837. 5 indexed citations

Zhang, Yong, Aaron Prodeus, Palak Sharma, et al.. (2021). A Novel Strategy for Off-the-Shelf T Cell Therapy Which Evades Allogeneic T Cell and NK Cell Rejection. Blood. 138(Supplement 1). 1711–1711. 1 indexed citations

Ruggiero, Eliana, Dai Liu, Aaron Prodeus, et al.. (2020). NTLA5001, a T Cell Product Candidate with CRISPR-Based Targeted Insertion of a High-Avidity, Natural, WT1-Specific TCR, Shows Efficacy in In Vivo Models of AML and ALL. Blood. 136(Supplement 1). 32–33. 1 indexed citations

Erin, Nuray, et al.. (2019). CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1. Cancer Immunology Immunotherapy. 69(1). 103–114. 10 indexed citations

Gariépy, Jean, et al.. (2019). A powerful ICOS agonist that enhances anti-tumor immune responses restored by immune checkpoint inhibitors. The Journal of Immunology. 202(1_Supplement). 71.5–71.5. 2 indexed citations

Prodeus, Aaron, et al.. (2018). Enhancing Checkpoint Inhibitor Therapy with Ultrasound Stimulated Microbubbles. Ultrasound in Medicine & Biology. 45(2). 500–512. 55 indexed citations

Prodeus, Aaron, Nicholas W. Fischer, Marzena Cydzik, et al.. (2018). A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo. Molecular Therapy — Nucleic Acids. 12. 350–358. 14 indexed citations

Fischer, Nicholas W., Aaron Prodeus, & Jean Gariépy. (2018). Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity. JCI Insight. 3(15). 11 indexed citations

Fischer, Nicholas W., et al.. (2018). Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome. JNCI Journal of the National Cancer Institute. 110(12). 1418–1421. 20 indexed citations

10.

Abdul‐Wahid, Aws, Marzena Cydzik, Nicholas W. Fischer, et al.. (2018). Serum‐derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re‐modeling of the extracellular matrix that favors the engraftment of CEA‐expressing tumor cells. International Journal of Cancer. 143(8). 1963–1977. 21 indexed citations

11.

Prodeus, Aaron, Aws Abdul‐Wahid, Nicholas W. Fischer, et al.. (2017). VISTA.COMP — an engineered checkpoint receptor agonist that potently suppresses T cell–mediated immune responses. JCI Insight. 2(18). 35 indexed citations

12.

Tsvetkova, Elena, et al.. (2016). B- and T-cell V(D)J-recombination excision circles as indicators of immunological reconstitution in children with acute lymphoblastic leukemia. Pediatric Hematology/Oncology and Immunopathology. 15(4). 42–50. 3 indexed citations

13.

Prodeus, Aaron & Jean Gariépy. (2016). Abstract B032: Targeting the PD-1/PD-L1 immune evasion axis with DNA aptamers. Cancer Immunology Research. 4(1_Supplement). B032–B032. 1 indexed citations

14.

Abdul‐Wahid, Aws, Marzena Cydzik, Aaron Prodeus, et al.. (2016). Induction of antigen‐specific T_H9 immunity accompanied by mast cell activation blocks tumor cell engraftment. International Journal of Cancer. 139(4). 841–853. 43 indexed citations

15.

Fischer, Nicholas W., Aaron Prodeus, David Malkin, & Jean Gariépy. (2016). p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis. Cell Cycle. 15(23). 3210–3219. 45 indexed citations

16.

Prodeus, Aaron, Aws Abdul‐Wahid, Nicholas W. Fischer, et al.. (2015). Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers. Molecular Therapy — Nucleic Acids. 4. e237–e237. 117 indexed citations

17.

Cydzik, Marzena, Aws Abdul‐Wahid, Soyeon Park, et al.. (2015). Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis. The FASEB Journal. 29(8). 3493–3505. 15 indexed citations

18.

Wu, Florence T.H., Christina R. Lee, Elena Bogdanovic, et al.. (2015). Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2. EMBO Molecular Medicine. 7(6). 770–787. 27 indexed citations

19.

Prodeus, Aaron, Marzena Cydzik, Aws Abdul‐Wahid, et al.. (2014). Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival. Molecular Therapy — Nucleic Acids. 3. e190–e190. 19 indexed citations

20.

Prodeus, Aaron, Bob Berno, Matthew K. Topham, & Richard M. Epand. (2012). The basis of the substrate specificity of the epsilon isoform of human diacylglycerol kinase is not a consequence of competing hydrolysis of ATP. Chemistry and Physics of Lipids. 166. 26–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact